Clinical Trials Browser

Phase 3 × INDUSTRY × Clear-cell metastatic renal cell carcinoma × Clear all

NCT07011719 2026-06-02

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Phase 3 Recruiting

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms